Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

gPROMS lyophilization Modeling Toolbox (or equal)

Closed
FDA-75F40126Q00155Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 513210
New
Federal
NIH NIAID Genedata Analyst bioinformatics software program
Solicitation # 7571TE26Q00254
The Department of Health and Human Services, through the Office of Mission Acquisition Solutions on behalf of the National Institutes of Health and the National Institute of Allergy and Infectious Diseases, intends to award a firm-fixed-price contract to Genedata (USA), Inc. for a 12-month renewal of the Genedata Analyst bioinformatics software. This acquisition is conducted under FAR Part 12 for commercial products and FAR Part 6.103-1, identifying Genedata as the only responsible source capable of meeting the requirements. The software is essential for the Viral Pathogenesis and Evolution Section to maintain continuity in its research on respiratory viral disease, vaccine development, and antiviral therapies, specifically by utilizing over 100 million historical gene-expression data points. Genedata Analyst provides critical capabilities for the statistical modeling of multi-omics data, including linear and nonlinear normalization methods such as LOWESS and Quantile Normalization. The software supports advanced analytical functions including parametric and non-parametric testing, mixed linear models, Principal Components Analysis, and machine learning tools like Decision Trees and Partial Least Square analysis. Additionally, it offers interactive visualization tools such as heat maps, scatter plots, and tree maps to support the identification of biomarkers and biological network characterization. The government is seeking capability statements from interested parties by September 14, 2026, to determine if a competitive procurement is warranted.
Omas Strategic Buying Center - Information Technology

POSTED

about 22 hours ago

DEADLINE

in 2 days

AI Contract Overview

Show more

The contract seeks the acquisition of a modeling and simulation platform from Siemens or an equally capable vendor to support advanced lyophilization process modeling for pharmaceutical manufacturing research under the FDA’s Office of Pharmaceutical Quality Research. The platform must feature a specialized Lyophilization Modeling Toolbox built on a high-performance, equation-oriented architecture capable of simulating the full transient dynamics of freeze-drying cycles—including freezing, primary drying, and secondary drying—using first-principles mathematical models rather than empirical data. It must integrate real-time operational data from manufacturing systems to enable Digital Twin validation, support comprehensive databases for tracking pharmaceutical material properties such as moisture content and chemical purity, and include automated tools for parameter estimation and Global Sensitivity Analysis to validate Quality by Design design spaces. The system must offer an open, customizable modeling environment with a robust API for integration with external tools like Python and Excel, along with scalable licensing options for both named users and small system deployments. Continuous maintenance and technical support must be provided through a multi-year subscription including software upgrades and alignment with Licensed Software Designation Agreements, with support delivered via email or web conference and one day of dedicated project support included. Online training resources from Altair must also be provided to end users. The contract is structured as a Firm Fixed Price acquisition under the Lowest Price Technically Acceptable (LPTA) evaluation methodology, with award expected after review of technically compliant responses submitted by the May 20, 2026 deadline. Performance must commence by July 10, 2026, with full delivery required no later than 30 days after contract award, and the 12-month contract period runs through July 9, 2027. The platform must be delivered in digital form via CD, DVD, or download, and all deliverables, including software and documentation, must meet Section 508 accessibility requirements, with contractors obligated to provide Accessibility Conformance Reports or checklists and remedy any non-compliance at their own expense. The contracting office requires full adherence to federal supply chain security clauses prohibiting the use of covered telecommunications equipment, ByteDance applications, and unmanned aircraft systems from certain foreign entities, with strict compliance required for subcontractors, privacy training, and small business subcontracting reporting. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and acceptance of deliverables will occur at the recipient site in Silver Spring, Maryland, with government inspection and formal acceptance to be completed within 30 business days of delivery.

General Info

Licenses advanced lyophilization simulation platform with real-time data, support, training, and scalable enterprise access.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

Contract Value

$35,449.44

NAICS

513210 - Software PublishersView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Awardee

SIEMENS GOVERNMENT TECHNOLOGIES INCView Profile

Award Issued Date

Documents

(1)

RFQ FDA-75F40126Q00155 gPROMS Lyophilization Modeling Toolbox

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts

Full Description

Show more

The objective is to establish a new contract for Siemens modeling and simulation platform license, featuring advanced process modeling.


FDA's OPQR has a requirement to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies. For Quoter’s software to be deemed acceptable, the following salient characteristics shall be met:


Lyophilization Modeling Toolbox
• Nonlinear Predictive Control (NL) for Lyophilization: Utilizes a highly parallelized, equation-oriented architecture optimized for high-performance computing (HPC) to perform large-scale, high-fidelity predictive modeling of time-dependent lyophilization cycles.
• Operational Intelligence & Data Integration: Must include a base system (such as XHQ) capable of aggregating and visualizing real-time operational data from multiple manufacturing sources to support "Digital Twin" validation.
• High-Fidelity Dynamic Simulation: Capable of simulating transient process events and complex equipment dynamics—including freezing, primary drying, and secondary drying—using first-principles mathematical equations rather than empirical data.
• Advanced Material & Thermodynamic Property Architecture: Supports the modeling of complex pharmaceutical formulations through comprehensive databases for excipients and APIs to track critical properties like moisture content and chemical purity throughout the stabilization process.
• Automated Global System Analysis (GSA): Built-in mathematical tools to perform parameter estimation from experimental data and Global Sensitivity Analysis (GSA) to identify influential process parameters and validate Quality by Design (QbD) design spaces.
• Customizable Modeling Environment & API: Features an open, equation-oriented language for creating custom first-principles models from scratch, complemented by a robust Application Programming Interface (API) for integration with external data systems like Python, Excel, or Electronic Lab Notebooks.
• Scalable Enterprise Access: Supports flexible licensing types including "Named User" for specific researchers and "Small System" base configurations to manage data exchange across physical or virtual assets.
• Regulatory-Grade Maintenance and Support: Provided through a multi-year subscription model that includes continuous software enhancement, technical support, and alignment with established Licensed Software Designation Agreements (LSDA).


Maintenance and Technical Support
At minimum the contractor must:
• Provide support via email and/or web conference.
• Licenses shall include maintenance, support, and any upgrades necessary to maintain the system.
• Provide one day of project support.


Training
The Contractor shall provide:
• Access to online training material in Altair resources


Please review the attached RFQ_FDA-75F40126Q00155 document for all details.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 22 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS